MARKET

CELU

CELU

Celularity Inc
NASDAQ
1.555
-0.085
-5.18%
After Hours: 1.540 -0.015 -0.96% 18:22 04/17 EDT
OPEN
1.560
PREV CLOSE
1.640
HIGH
1.778
LOW
1.500
VOLUME
56.80K
TURNOVER
--
52 WEEK HIGH
5.22
52 WEEK LOW
1.001
MARKET CAP
37.02M
P/E (TTM)
-1.0230
1D
5D
1M
3M
1Y
5Y
1D
Celularity welcomes CMS action on Medicare LCD for skin substitutes products
TipRanks · 6d ago
Weekly Report: what happened at CELU last week (0407-0411)?
Weekly Report · 6d ago
Celularity Welcomes CMS Action on Medicare Local Coverage Determination for Skin Substitutes Products
Barchart · 6d ago
Celularity announces publication highlighting potential of CYNK-001
TipRanks · 04/07 12:26
Celularity Announces Publication Titled "Senescence, NK cells, And Cancer: Navigating The Crossroads Of Aging And Disease" In The April 4, 2025, Issue Of 'Frontiers in Immunology'
Benzinga · 04/07 12:08
Weekly Report: what happened at CELU last week (0331-0404)?
Weekly Report · 04/07 09:45
Celularity Delays Yearly Report Filing Amid Financial Challenges
TipRanks · 03/31 22:29
CELULARITY FILES FOR NON-TIMLEY 10-K - SEC FILING
Reuters · 03/31 21:46
More
About CELU
Celularity Inc. is a regenerative and cellular medicine company. It is developing and commercializing advanced biomaterial products and allogeneic, cryopreserved, placental-derived cell therapies, all derived from the postpartum placenta. Its therapeutic programs that target aging-related diseases, including degenerative diseases, cancer, and immune disorders, using mesenchymal-like adherent stromal cells, T-cells engineered with CAR (CAR T-cells), and genetically modified and unmodified natural killer (NK) cells. It develops, manufactures and commercializes advanced biomaterial products derived from structural tissue components of the postpartum placental tissues, including the umbilical cord. Its advanced biomaterials include Celularity Tendon Wrap, FUSE Bone Void Filler and Celularity Placental Matrix. Its advanced biomaterial products include Biovance, Interfyl and Rebound products. Its platform is Celularity IMPACT (Immuno-Modulatory Placental-derived Allogeneic Cell Therapy).

Webull offers Celularity Inc stock information, including NASDAQ: CELU real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CELU stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CELU stock methods without spending real money on the virtual paper trading platform.